Individualized ASO therapy for rare diseases
Annemieke Aartsma-Rus is a Professor of Translational Genetics at the Leiden University Medical Center. She was one of the pioneers of antisense oligonucleotide (ASO)-mediated exon skipping therapy for Duchenne muscular dystrophy (DMD). Her work focuses on the personalized approach to delivering exo...
Wedi'i Gadw mewn:
| Fformat: | Artigo |
|---|---|
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Portfolio
2023-02-01
|
| Cyfres: | Communications Medicine |
| Mynediad Ar-lein: | https://doi.org/10.1038/s43856-023-00255-3 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|